The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging
Reference134 articles.
1. Cancer facts and figures 1995,1995
2. The positive predictive value of mammography;Kopans;AJR,1992
3. Occult breast cancer: prevalence and radiographic detectability;Pollei;Radiology,1987
4. The prevalence of carcinoma in palpable versus impalpable, mammographically detected lesions;Bassett;AJR,1991
5. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit;Tabar;J Epidemiol Community Health,1989
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The application of radionuclide therapy for breast cancer;Frontiers in Nuclear Medicine;2024-01-10
2. Diagnostic modalities and radiopharmaceuticals with particular importance of technetium-99m (99mTc);Chinese Journal of Academic Radiology;2023-11-28
3. Nuclear Oncology;Synopsis of Pathophysiology in Nuclear Medicine;2023
4. Enhancement of Anti-Tumoral Properties of Paclitaxel Nano-Crystals by Conjugation of Folic Acid to Pluronic F127: Formulation Optimization, In Vitro and In Vivo Study;Molecules;2022-11-16
5. Role of Nuclear Medicine in Breast Cancer;Breast Cancer;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3